Search for a command to run...
Promoters and Public have reduced their holdings, with YOY declines of -2.18% and -2.22%, respectively, while sector averages show no change.
Institutional investment has increased by 1.80% YOY, indicating some confidence; however, this is insufficient to offset the overall negative sentiment.
Mankind Pharma's performance diverges from the sector, as leading stocks like SANOFICONR are experiencing significant institutional buying, highlighting Mankind's relative weakness.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter Holdings | 76.51% | 74.88% | 74.87% | 74.87% | 72.71% | 72.7% | 72.68% | 72.67% | |
2Public Holdings | 6.96% | 4.11% | 3.6% | 2.86% | 2.89% | 2.93% | 2.79% | 2.61% | |
3Foreign Investors | 6.74% | 9.87% | 11.58% | 12.37% | 13.34% | 12.92% | 13.07% | 12.83% | |
4Domestic Investors | 9.79% | 11.14% | 9.95% | 9.9% | 11.06% | 11.45% | 11.46% | 11.89% |